loadpatents
name:-0.02923583984375
name:-0.026488065719604
name:-0.0095221996307373
VERSCHUEREN; Wim Gaston Patent Filings

VERSCHUEREN; Wim Gaston

Patent Applications and Registrations

Patent applications and USPTO patent grants for VERSCHUEREN; Wim Gaston.The latest application filed is for "fused heterocycle derivatives".

Company Profile
9.27.29
  • VERSCHUEREN; Wim Gaston - Berchem BE
  • Verschueren; Wim Gaston - Berchem Antwerpen
  • Verschueren; Wim Gaston - De Wittestraat BE
  • Verschueren; Wim Gaston - Anteverpen BE
  • Verschueren; Wim Gaston - Berchern BE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fused Heterocycle Derivatives
App 20220242879 - KUDUK; Scott D. ;   et al.
2022-08-04
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 11,078,193 - Vandyck , et al. August 3, 2
2021-08-03
Cyclized Sulfamoylarylamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20210179635 - VENDEVILLE; Sandrine Marie Helene ;   et al.
2021-06-17
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,995,064 - Vandyck , et al. May 4, 2
2021-05-04
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20210024462 - VANDYCK; Koen ;   et al.
2021-01-28
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,875,876 - Vendeville , et al. December 29, 2
2020-12-29
Amide Derivatives Useful In The Treatment Of Hbv Infection Or Hbv-induced Diseases
App 20200352925 - KESTELEYN; Bart Rudolf Romanie ;   et al.
2020-11-12
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20200255373 - Kind Code
2020-08-13
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,676,429 - Vandyck , et al.
2020-06-09
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20200039931 - VANDYCK; Koen ;   et al.
2020-02-06
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,457,638 - Vandyck , et al. Oc
2019-10-29
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,450,270 - VanDyck , et al. Oc
2019-10-22
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 10,160,743 - Vandyck , et al. Dec
2018-12-25
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20180141905 - VANDYCK; Koen ;   et al.
2018-05-24
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20180127361 - VANDYCK; Koen ;   et al.
2018-05-10
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 9,884,818 - Vandyck , et al. February 6, 2
2018-02-06
Cyclized Sulfamoylarylamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20170002025 - VENDEVILLE; Sandrine Marie Helene ;   et al.
2017-01-05
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160347741 - VANDYCK; Koen ;   et al.
2016-12-01
Glyoxamide Substituted Pyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160176817 - VANDYCK; Koen ;   et al.
2016-06-23
Sulphamoylthiophenamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160115149 - VANDYCK; Koen ;   et al.
2016-04-28
Sulphamoylpyrrolamide Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20160115125 - VANDYCK; Koen ;   et al.
2016-04-28
4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B
Grant 9,233,933 - Vandyck , et al. January 12, 2
2016-01-12
Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis B
Grant 9,156,839 - Vandyck , et al. October 13, 2
2015-10-13
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20150274653 - Vandyck; Koen ;   et al.
2015-10-01
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20150266890 - Vandyck; Koen ;   et al.
2015-09-24
Hetero-bicyclic derivatives as HCV inhibitors
Grant 9,126,986 - Vandyck , et al. September 8, 2
2015-09-08
Fused Bicyclic Sulfamoyl Derivatives And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20150218159 - Vandyck; Koen ;   et al.
2015-08-06
4,4-disubstituted-1,4-dihydropyrimidines And The Use Thereof As Medicaments For The Treatment Of Hepatitis B
App 20150005295 - Vandyck; Koen ;   et al.
2015-01-01
Hetero-Bicyclic Derivatives As HCV Inhibitors
App 20140357626 - Vandyck; Koen ;   et al.
2014-12-04
Hetero-bicyclic derivatives as HCV inhibitors
Grant 8,815,849 - Vandyck , et al. August 26, 2
2014-08-26
Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
Grant 8,580,981 - Wigerinck , et al. November 12, 2
2013-11-12
Hetero-Bicyclic Derivatives as HCV Inhibitors
App 20130123244 - Vandyck; Koen ;   et al.
2013-05-16
Process For The Preparation Of (3r,3as,6ar)-hexahydrofuro [2,3-b] Furan-3-yl (1s,2r)-3-[[(4-aminophenyl) Sulfonyl] (isobutyl) Amino]-1-benzyl-2-hydroxypropylcarbamate
App 20110160468 - Wigerinck; Piet Tom Bert Paul ;   et al.
2011-06-30
Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
Grant 7,863,306 - Surleraux , et al. January 4, 2
2011-01-04
Homogeneous Time Resolved Fluorescence Based Test System
App 20100280268 - Dams; Gery Karel Julia ;   et al.
2010-11-04
Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
Grant 7,763,641 - Vendeville , et al. July 27, 2
2010-07-27
Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
Grant 7,659,404 - Surleraux , et al. February 9, 2
2010-02-09
Broadspectrum 2-amino-benzoxazole Sulfonamide Hiv Protease Inhibitors
App 20100029632 - SURLERAUX; Dominique Louis Nestor Ghislain ;   et al.
2010-02-04
Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
Grant 7,622,490 - Surleraux , et al. November 24, 2
2009-11-24
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
Grant 7,595,334 - Surleraux , et al. September 29, 2
2009-09-29
Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
Grant 7,358,239 - De Bruyn , et al. April 15, 2
2008-04-15
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
Grant 7,244,752 - Surleraux , et al. July 17, 2
2007-07-17
Broadspectrum 2-(substituted-amino)-benzoxazole Sulfonamide Hiv Protease Inhibitors
App 20070135447 - SURLERAUX; Dominique Louis Nestor Ghislain ;   et al.
2007-06-14
Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
App 20050159406 - De Bruyn, Marcel Frans Leopold ;   et al.
2005-07-21
Pyrrolidinyl, piperdinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
Grant 6,900,222 - De Bruyn , et al. May 31, 2
2005-05-31
(Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
Grant 6,852,714 - Wigerinck , et al. February 8, 2
2005-02-08
Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
App 20040116485 - Surleraux, Dominique Louis Nestor Ghislain ;   et al.
2004-06-17
(Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
Grant 6,747,045 - Wigerinck , et al. June 8, 2
2004-06-08
Broadspecturm 2-amino-benzoxazole sulfonamide hiv protease inhibitors
App 20040106661 - Surleraux, Dominique Louis Nestor Ghislain ;   et al.
2004-06-03
(Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
App 20030149093 - Wigerinck, Piet Tom Bert Paul ;   et al.
2003-08-07
(Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
App 20030083365 - Wigerinck, Piet Tom Bert Paul ;   et al.
2003-05-01
(Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
Grant 6,133,277 - Wigerinck , et al. October 17, 2
2000-10-17
Vasoconstrictive dihydrobenzopyran derivatives
Grant 6,100,268 - Van Lommen , et al. August 8, 2
2000-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed